다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of liver cancer = 대한간암학회지, v.20 no.1, 2020년, pp.78 - 83
Lee, Jin Yong (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea) , Yoo, Jeong-Ju (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea) , Chun, Seong Joon (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea) , Bae, Sun Hyun (Department of Radiology and Research Institute of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea) , Lee, Jae Myeong (Department of Radiation Oncology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea) , Kim, Sang Gyune (Division of Gast) , Kim, Young Seok
AI-Helper
Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Additionally, hepatic arterial infusion chemotherapy has been used as a treatment option for advanced HCC. Here, we report a case of sustained partial response in a patient with advance...
1 Forner A Llovet JM Bruix J Hepatocellular carcinoma Lancet 2012 379 1245 1255 22353262
2 Kwak HW Park JW Nam BH Yu A Woo SM Kim TH Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area J Gastroenterol Hepatol 2014 29 820 829 24325272
3 Marrero JA Kulik LM Sirlin CB Zhu AX Finn RS Abecassis MM Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology 2018 68 723 750 29624699
4 European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of hepatocellular carcinoma J Hepatol 2018 69 182 236 29628281
5 Song DS Song MJ Bae SH Chung WJ Jang JY Kim YS A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis J Gastroenterol 2015 50 445 454 25027973
6 Kim SJ Jang BK Hwang JS A case of hepatocellular carcinoma with portal vein tumor thrombosis treated by hepatic artery injection chemotherapy and radiotherapy J Liver Cancer 2017 17 158 162
7 Saeki I Yamasaki T Maeda M Hisanaga T Iwamoto T Matsumoto T Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparison with sorafenib therapy PLoS One 2019 14 e0218136 31194789
8 Choi JH Chung WJ Bae SH Song DS Song MJ Kim YS Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis Cancer Chemother Pharmacol 2018 82 469 478 29982870
9 Han KH Seong J Kim JK Ahn SH Lee DY Chon CY Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis Cancer 2008 113 995 1003 18615601
10 Nouso K Miyahara K Uchida D Kuwaki K Izumi N Omata M Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan Br J Cancer 2013 109 1904 1907 24008659
11 Sumie S Yamashita F Ando E Tanaka M Yano Y Fukumori K Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization AJR Am J Roentgenol 2003 181 1327 1334 14573429
12 Zhao Q Zhu K Yue J Qi Z Jiang S Xu X Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis Ther Clin Risk Manag 2017 13 21 31 28053537
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.